Throughout the past decade, growth stage organizations have sought ways to streamline technology processes, leverage data to make impactful decisions, and empower their staff to break through barriers created by time constraints. In 2021, Zack Miller (CEO) and Chris Godsey (CTO) came together to discuss a rising trend within the Life Sciences industry; rapid growth. Organizations set to produce a drug, technology or process for patients all face the need to rapidly scale, without the luxury of time. Clinical trials and the associated regulatory demands stretch that problem even further, leaving little room for error or delays.